Company Filing History:
Years Active: 2019
Title: Mark S Segal: Innovator in Bone Marrow-Derived Cell Modulation
Introduction
Mark S Segal is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of bone marrow-derived cells. His innovative work has the potential to impact various medical treatments.
Latest Patents
Mark S Segal holds a patent titled "Materials and methods for modulating activity of bone marrow derived cells." This invention provides methods for the recruitment of bone marrow-derived cells, including bone marrow-derived endothelial cells (BMDEC), and enhances their function through the administration of relaxin. The methods outlined in this patent can be utilized in treating conditions that benefit from the recruitment of these specialized cells.
Career Highlights
Mark S Segal is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore innovative solutions in the biomedical field. His research focuses on the therapeutic applications of bone marrow-derived cells, contributing to advancements in regenerative medicine.
Collaborations
Mark has collaborated with Kirk P Conrad, enhancing the research efforts in their respective fields. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Mark S Segal's contributions to the modulation of bone marrow-derived cells highlight his role as an influential inventor in the biomedical field. His patent and ongoing research have the potential to lead to significant advancements in medical treatments.